This company listing is no longer active
9GM0 Stock Overview
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
G Medical Innovations Holdings Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.50 |
| 52 Week High | US$47.60 |
| 52 Week Low | US$0.14 |
| Beta | -1.01 |
| 1 Month Change | -70.69% |
| 3 Month Change | -89.27% |
| 1 Year Change | -98.76% |
| 3 Year Change | -69.67% |
| 5 Year Change | -98.41% |
| Change since IPO | -99.01% |
Recent News & Updates
Recent updates
Shareholder Returns
| 9GM0 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -70.7% | 1.9% | -0.4% |
| 1Y | -98.8% | -5.1% | 3.4% |
Return vs Industry: 9GM0 underperformed the German Healthcare industry which returned -28.3% over the past year.
Return vs Market: 9GM0 underperformed the German Market which returned -9% over the past year.
Price Volatility
| 9GM0 volatility | |
|---|---|
| 9GM0 Average Weekly Movement | 46.4% |
| Healthcare Industry Average Movement | 5.3% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in DE Market | 9.8% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 9GM0's share price has been volatile over the past 3 months.
Volatility Over Time: 9GM0's weekly volatility has decreased from 357% to 46% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | Yacov Geva | https://gmedinnovations.com |
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company’s products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics.
G Medical Innovations Holdings Ltd Fundamentals Summary
| 9GM0 fundamental statistics | |
|---|---|
| Market cap | €3.87m |
| Earnings (TTM) | -€21.17m |
| Revenue (TTM) | €3.99m |
1.0x
P/S Ratio-0.2x
P/E RatioIs 9GM0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9GM0 income statement (TTM) | |
|---|---|
| Revenue | US$4.36m |
| Cost of Revenue | US$8.91m |
| Gross Profit | -US$4.56m |
| Other Expenses | US$18.53m |
| Earnings | -US$23.08m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.11 |
| Gross Margin | -104.57% |
| Net Profit Margin | -529.84% |
| Debt/Equity Ratio | -71.9% |
How did 9GM0 perform over the long term?
See historical performance and comparison